| Primary |
| Anaesthesia |
20.0% |
| Prophylaxis |
20.0% |
| Depression |
13.3% |
| Product Used For Unknown Indication |
13.3% |
| Cardiovascular Disorder |
6.7% |
| Maintenance Of Anaesthesia |
6.7% |
| Myoclonus |
6.7% |
| Sedation |
6.7% |
| Sedative Therapy |
6.7% |
|
| Electroencephalogram Abnormal |
25.0% |
| Renal Failure Acute |
25.0% |
| Respiration Abnormal |
25.0% |
| Status Epilepticus |
25.0% |
|
| Secondary |
| Product Used For Unknown Indication |
36.2% |
| Ill-defined Disorder |
8.2% |
| Drug Use For Unknown Indication |
7.1% |
| Hypertension |
4.1% |
| Sepsis |
3.7% |
| Arthritis |
3.7% |
| Kawasaki's Disease |
3.4% |
| Electrolyte Substitution Therapy |
3.3% |
| Infection |
3.3% |
| Analgesic Therapy |
3.2% |
| Restlessness |
3.1% |
| Sedation |
2.9% |
| Stupor |
2.9% |
| Pain |
2.8% |
| Constipation |
2.7% |
| Pyrexia |
2.0% |
| Convulsion |
1.9% |
| Delirium |
1.9% |
| Insomnia |
1.9% |
| Pain Management |
1.8% |
|
| Toxic Epidermal Necrolysis |
24.4% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
8.9% |
| Hyponatraemia |
5.6% |
| Staphylococcal Infection |
5.6% |
| Wrong Technique In Drug Usage Process |
5.6% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
4.4% |
| Nausea |
4.4% |
| Rash |
4.4% |
| Vitamin K Deficiency |
4.4% |
| Vomiting |
4.4% |
| Respiratory Depression |
3.3% |
| Sinusitis |
3.3% |
| Somnolence |
3.3% |
| Tricuspid Valve Incompetence |
3.3% |
| Ventricular Hypokinesia |
3.3% |
| Completed Suicide |
2.2% |
| Myoclonus |
2.2% |
| Respiratory Failure |
2.2% |
| Thyroid Cancer |
2.2% |
| White Blood Cell Count Decreased |
2.2% |
|
| Concomitant |
| Drug Use For Unknown Indication |
12.2% |
| Prophylaxis |
11.3% |
| Product Used For Unknown Indication |
8.6% |
| Ureteral Stent Insertion |
7.3% |
| Ureteral Stent Removal |
7.3% |
| Sedation |
7.0% |
| Infection |
6.0% |
| Infection Prophylaxis |
5.2% |
| Hypertension |
4.3% |
| Insomnia |
3.9% |
| Multiple Myeloma |
3.8% |
| Fluid Replacement |
3.5% |
| Diuretic Therapy |
3.2% |
| Anticoagulant Therapy |
3.0% |
| Prophylaxis Against Graft Versus Host Disease |
3.0% |
| Pneumonia |
2.7% |
| Pain |
2.2% |
| Constipation |
1.9% |
| Thrombocytopenia |
1.9% |
| Vomiting |
1.9% |
|
| Respiratory Failure |
21.6% |
| Renal Impairment |
10.8% |
| Septic Shock |
8.3% |
| Toxic Epidermal Necrolysis |
7.1% |
| Viral Infection |
6.6% |
| White Blood Cell Count Decreased |
5.0% |
| Hepatic Function Abnormal |
4.6% |
| Wrong Technique In Drug Usage Process |
4.6% |
| Renal Failure Acute |
4.1% |
| Thrombocytopenia |
4.1% |
| Anaphylactic Shock |
3.3% |
| Rhabdomyolysis |
3.3% |
| Pneumonia |
2.5% |
| Vomiting |
2.5% |
| Death |
2.1% |
| Sepsis |
2.1% |
| Suicide Attempt |
2.1% |
| White Blood Cell Count Increased |
2.1% |
| Cauda Equina Syndrome |
1.7% |
| Coma |
1.7% |
|
| Interacting |
| Drug Use For Unknown Indication |
40.0% |
| Anaesthesia |
17.1% |
| Restless Legs Syndrome |
11.4% |
| Essential Hypertension |
8.6% |
| General Anaesthesia |
5.7% |
| Angina Pectoris |
2.9% |
| Epilepsy |
2.9% |
| Hypercholesterolaemia |
2.9% |
| Hypothyroidism |
2.9% |
| Pain |
2.9% |
| Polysubstance Dependence |
2.9% |
|
| Drug Interaction |
42.9% |
| Paranoia |
28.6% |
| Rhabdomyolysis |
14.3% |
| Sedation |
14.3% |
|
